Cannara Biotech (CSE:LOVE, OTCQB:LOVFF), based in Montreal, Canada, is focused on the production and sale of premium cannabis and cannabis-infused products for the Canadian and international markets, today announced that Lennie Ryer, Cannara Biotech’s Chief Financial Officer, will present live at VirtualInvestorConferences.com on August 1.
DATE: Thursday, August 1
TIME: 10:30 AM – 11:00 AM ET
This will be a live, interactive online event where investors are invited to ask the company questions in real time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.VirtualInvestorConferences.com.
Recent Company Highlights
- Q3 results released on July 25, reflecting a strong financial position.
- Construction of Phase 1, 170,000 square feet, completion by end of the summer.
- Submission of security evidence package to Health Canada in the coming weeks.
- Cultivation license for Phase 1 expected by end of the calendar year.
- The Company, through its subsidiary, ShopCBD.com, is launching in two weeks a U.S. hemp-based CBD online e-commerce platform, www.shopCBD.com, exclusively for the U.S. market.
About Cannara Biotech
Cannara Biotech (OTCQB: LOVFF) (CSE: LOVE) is building one of the largest indoor cannabis cultivation facilities (625,000 square feet) in Canada and the largest in the province of Quebec. Leveraging Quebec’s low cost of electricity -the lowest in Canada, Cannara Biotech’s facility will produce and sell premium indoor grown cannabis and cannabis-infused products for the Canadian and international markets. For more information, visit our website: www.cannara.ca
About Virtual Investor ConferencesSM
Virtual Investor Conferences is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to meet and present directly with investors.
A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group’s suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/